Antibiotic overkill leads to widespread side effects such as C. diff, large study finds
By
Alicia Lasek
Apr 02, 2023
“We’re talking about hundreds of thousands of adverse events severe enough that these patients needed additional care from a doctor,” an investigator said.
Soaring dementia treatment costs leave care providers to find solutions: report
By
Alicia Lasek
Nov 02, 2022
The growing needs of patients will put the onus on healthcare providers and other stakeholders to increase access to high-quality dementia care services, the Milken Institute reports.
Treatment patterns, not genetics, drive prostate cancer disparities, study finds
By
Alicia Lasek
May 29, 2023
Prostate cancer, which affects 1 in 11 men aged 70 and older, has some of the largest disparities in outcomes across all cancer types, investigators say.
MedPAC finds single post-acute payment system feasible but says smaller-scale fix might be better
By
Kimberly Marselas
Jun 16, 2023
An attempt to unify payments for providers across all types of post-acute care is “analytically within reach,” but extensive policy changes that would likely be needed,
LTC Properties had its strongest investment year since 2015, company leaders said Thursday, with Chairman and CEO Wendy Simpson touting $170 million in annual investment as proof of a “hard-won positive...
On eve of Alzheimer’s drug decision, Congress critiques FDA for Aduhelm review failures
By
Alicia Lasek
Jan 03, 2023
An “atypical review process and corporate greed” factored into the FDA’s approval of Alzheimer’s drug Aduhelm in 2021, congressional investigators say. They recommend sticking to protocol...
Some providers dubious as return to pre-COVID ‘normal’ gets official OK
By
Kimberly Marselas
Oct 07, 2022
Providers are still clamoring for answers about how to best comply with a series of new rules and recommendations issued by federal regulators over the last two weeks, officials acknowledged during a nursing...
Nursing home providers help to design, refine facility IP program
By
Alicia Lasek
Apr 26, 2023
In partnership with providers, an infection control peer coaching program has been updated to improve its utility amid competing facility priorities and staffing shortages.
Depression drug eases Alzheimer’s agitation; new death in lecanemab trial raises concerns
By
Alicia Lasek
Nov 30, 2022
Two drugs in late-stage clinical trials are making news, one as a potential treatment for agitation, and the other for evidence of bleeding risk.
Cognitive skills decline with age, but the brain may compensate, study finds
By
Alicia Lasek
Sep 19, 2022
As it ages, the brain may attempt to make up for decline in some areas while it loses function elsewhere, investigators report.